ePurines
Sandy
About ePurines
ePurines, Inc is a drug development company focused on innovative purinergic-based therapies for obesity, metabolic syndrome renal and liver diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $65.0K
- Funding stage: Seed
- Last round: Seed (Mar 2022)
- Website: epurines.com
- Phone: 801-598-3389
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/epurines-204564 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.